Brave little world - Spheroids as an in vitro model to study tumor-immune-cell interactions

被引:72
作者
Gottfried, Eva
Kunz-Schughart, Leoni A.
Andreesen, Reinhard
Kreutz, Marina [1 ]
机构
[1] Univ Regensburg, Dept Hematol & Oncol, D-93042 Regensburg, Germany
[2] Univ Regensburg, Inst Pathol, D-93042 Regensburg, Germany
关键词
spheroid; immune escape; dendritic cell; monocyte; lactic acid; lactate; tumor microenvironment;
D O I
10.4161/cc.5.7.2624
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Multicellular tumor spheroids (MCTS) are a well-established 3-D in vitro model system that reflects the pathophysiological in vivo situation in tumor microregions and of avascular micrometastatic sites. Because monocytes and other immune cells infiltrate into MCTS of different origin, such spheroid cocultures are a valuable, still underestimated tool to systematically study heterologous interactions between tumor and immune cells. The present article gives a brief overview on work that has been published on tumor-immune cell interactions in MCTS and also summarizes mechanisms of immune suppression in the tumor milieu focussing on myeloid cells. Using the coculture model, we recently demonstrated that tumor-derived lactic acid is a potent modulator of human monocyte as lactic acid inhibited the differentiation of monocytes (MO) into dendritic cells (DC) and also impaired antigen presentation. We show herein, that the capacity of various tumor cells in MCTS to secrete lactic acid differs up to tenfold, suggesting that this capacity is dependent on the tumor cell type. It is further demonstrated that lactic acid disturbs the migration of MO into MCTS as infiltration could be increased by blocking lactic acid production. We therefore discuss lactic acid which accumulates in many tumors and tumor microregions as a potent immune suppressor for MO/DC in the tumor milieu and conclude that these data are highly relevant for adoptive immunotherapy protocols with DC.
引用
收藏
页码:691 / 695
页数:5
相关论文
共 85 条
[1]  
Almand B, 2000, CLIN CANCER RES, V6, P1755
[2]  
AMBE K, 1989, CANCER, V63, P496, DOI 10.1002/1097-0142(19890201)63:3<496::AID-CNCR2820630318>3.0.CO
[3]  
2-K
[4]  
AUDRAN R, 1994, CANCER IMMUNOL IMMUN, V39, P299, DOI 10.1007/s002620050129
[5]   In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas [J].
Bell, D ;
Chomarat, P ;
Broyles, D ;
Netto, G ;
Harb, GM ;
Lebecque, S ;
Valladeau, J ;
Davoust, J ;
Palucka, KA ;
Banchereau, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) :1417-1425
[6]  
BISWAS SK, 2005, BLOOD
[7]   INTERLEUKIN-10 DIFFERENTIALLY REGULATES B7-1 (CD80) AND B7-2 (CD86) EXPRESSION ON HUMAN PERIPHERAL-BLOOD DENDRITIC CELLS [J].
BUELENS, C ;
WILLEMS, F ;
DELVAUX, A ;
PIERARD, G ;
DELVILLE, JP ;
VELU, T ;
GOLDMAN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) :2668-2672
[8]   Hypoxia-induced gene expression in human macrophages - Implications for ischemic tissues and hypoxia-regulated gene therapy [J].
Burke, B ;
Giannoudis, A ;
Corke, KP ;
Gill, D ;
Wells, M ;
Ziegler-Heitbrock, L ;
Lewis, CE .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (04) :1233-1243
[9]  
Chaux P, 1996, LAB INVEST, V74, P975
[10]   Tumor-associated macrophages: The double-edged sword in cancer progression [J].
Chen, JJW ;
Lin, YC ;
Yao, PL ;
Yuan, A ;
Chen, HY ;
Shun, CT ;
Tsai, MF ;
Chen, CH ;
Yang, PC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (05) :953-964